I don't know the answer. All I know right now is the company is very busy working on getting new/additional contracts. It is safe to assume that once the revenue starts coming in, Medify will do what is necessary to get on a higher board. A company with about 10 employees and low overhead that has contracts for 40 million USD annually does not belong on the pink sheets.
It sucks, but I guess we have to be patient.
Remember that quote attributed to Warren Buffet: "be scared when others are greedy and be greedy only when others are scared"...something like that. Others may panic and sell, I'm ready to buy more when I get more money.
News 
Market Data 
Discover 
